连这部火遍朋友圈的电影里,也有这种救命神器!

2016-09-19 姬无力 医学界

中秋小长假,有一部韩国电影刷爆了朋友圈。不卖关子,它就是被誉为“2016韩国最成功商业片”的《釜山行》。 尚未观影的粉丝们请放心,本文不含剧透,鉴影毕竟也不是小编的强项嘛~今天小编要着重梳理的,是影片中一个一闪而过的场景: 虽然如图这样循环往复有点……魔性,但没看清楚也不要紧,因为小编在观影时,条件反射、眼疾手快地截了图并发送到了好友圈:

中秋小长假,有一部韩国电影刷爆了朋友圈。不卖关子,它就是被誉为“2016韩国最成功商业片”的《釜山行》。



尚未观影的粉丝们请放心,本文不含剧透,鉴影毕竟也不是小编的强项嘛~今天小编要着重梳理的,是影片中一个一闪而过的场景:



虽然如图这样循环往复有点……魔性,但没看清楚也不要紧,因为小编在观影时,条件反射、眼疾手快地截了图并发送到了好友圈:




喏,就是在丧尸片里仍坚守工作岗位、尽职尽责的AED(自动体外除颤仪)!


按套路,这部影片带给小编的感触理应到此为止。但正如上图所示,有小伙伴颇不以为意地指出:韩国到处都是这个东西(AED)——没什么好大惊小怪的。


小编自惭形秽。一方面,虽然叔没出过国门,但对海外公共场所普及的AED早有耳闻;另一方面,大体而言,我国的AED主要集中在京沪两地小部分公共场所。即使在编辑本文时,小编咨询了周围的同事,得到的答案也不过是:在人X广场、陕X南路这些比较大的站台,应该会有的吧!


看,也只是应该。看来不是编辑们观察不仔细,就是国内配备AED的场所,实在是太稀罕了……


AED,究竟是何方神圣?


AED(Automatic External Defibrillator),即适用于心源性猝死患者急救的自动体外除颤仪是一项供非专业医疗人士使用的社会化急救产品。AED的目的是在现场,由公众使用,为心搏骤停患者进行及时的电击抢救。在猝死患者的急救中,AED可以大大提高抢救的成功率。


注意小编划出的这几个重点(敲黑板):社会化急救产品、公众、心搏骤停。


换句话说,AED是一种供非专业人员使用、用于抢救心搏骤停患者的医疗设备。


但目前在我国,AED属于第三类医疗器械,根据我国对第三类医疗器械的管理规定,使用者必须是专业的医疗人员。好在前不久恰逢世界急救日(9月10日),国家食药监总局(CFDA)表示,拟将AED从第三类医疗器械中分开,单独予以分类。


这样,经过急救培训的非医务人员使用AED时将不会存在法律障碍。


为什么AED能够救命?


据统计,我国每年有54万多人死于心脏性猝死,导致心搏骤停最主要的原因是心室颤动(Ventricular Fibrillation,VF,简称室颤)。


发生室颤时,心室丧失有效的整体收缩能力,心脏无排血,心、脑等重要器官和周围组织失去血液灌注。此时,要想有效纠正恶性心律失常,最有效的方法是除颤。除颤每延迟1分钟,存活率会下降3%~4%


这存活率,可比丧尸围城可怕多了……


除颤(Defibrillation),即利用医疗器械或特定药品终止心脏颤动的过程。一般除颤时,最常用也最有效的方法是电除颤(此外,还包括药物除颤和手法除颤)。与传统除颤仪相比,AED具有便携、智能、易操作等特点。因此,AED也被称为“傻瓜除颤仪”。


操作AED仅需4步:


第一步,打开机器的电源开关;

第二步,取出电极片,把电极片按要求贴在病人身体的指定部位;

第三步,机器分析病人的心律是否为室颤状态;

第四步,如果确实发生室颤,机器会提示所有人后退并进行自动充电。当充电完毕后,充电键会变红。之后,操作者按下充电键,这一次电击除颤的治疗就完成了。



2分钟学会自动体外除颤仪的用法

抢救成功率低,欠缺的不只有硬件


据统计,我国每年有54万人死于心源性猝死,而院外抢救心跳骤停的成功率最高不超过3%。造成这一现状的原因除了上面提到的AED配备极为有限外,国民急救知识缺乏,以及前面提到的“法外开恩”的欠缺均难辞其咎。


数据显示,即使在内地院外急救普及率最高的深圳市,每100人中只有1个人接受过院外急救培训,香港这一比例是1:30,新加坡为1:5,而美国有三分之一的人口接受过院外急救培训,比美国更高的澳大利亚有一半人口学过院外急救。


在前不久召开的ESC 2016(2016欧洲心脏病学年会)上发表的一项法国最新研究也同样表明,在保障硬件设施齐全的前提下,院前急救教育是改善公众应用AED的基石:基本生命支持教育可显著改善心跳骤停者的存活率(OR=1.64,95%CI:1.17~2.31;P=0.004),而AED的配备密度则无此功效。


基本生命支持教育的普及,任重道远!


不过好在,如今CFDA放宽AED的使用限制,或许是我国院前急救的普及和进一步改革推进的前奏。就在小编编写本文时,叔搜索到以下照片: 


令人欣慰的是,目前,我国的公众院前急救正在逐步普及、推广。也许不久后的某一天,在咱们本土的电影里,AED的出现不会再引起界叔的大惊小怪——


“是除颤仪吗?中国到处都是这个东西。”


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1670896, encodeId=ef2a16e0896a0, content=<a href='/topic/show?id=92bf60e12b4' target=_blank style='color:#2F92EE;'>#朋友圈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60712, encryptionId=92bf60e12b4, topicName=朋友圈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca6426781117, createdName=axin018, createdTime=Mon Mar 06 06:18:00 CST 2017, time=2017-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134217, encodeId=54cb13421e0b, content=急救医学之路, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb571956164, createdName=187清风, createdTime=Sat Sep 24 10:07:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134218, encodeId=a8a113421870, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb571956164, createdName=187清风, createdTime=Sat Sep 24 10:07:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131589, encodeId=cce813158965, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:51:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131586, encodeId=8d93131586e6, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131587, encodeId=958d13158e8a, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131588, encodeId=4b2913158832, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131046, encodeId=f337131046f9, content=学习了啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e291719269, createdName=大旺旺, createdTime=Mon Sep 19 21:28:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130946, encodeId=141a130946a3, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 19 16:39:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130947, encodeId=0f3f13094e53, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 19 16:39:00 CST 2016, time=2016-09-19, status=1, ipAttribution=)]
    2017-03-06 axin018
  2. [GetPortalCommentsPageByObjectIdResponse(id=1670896, encodeId=ef2a16e0896a0, content=<a href='/topic/show?id=92bf60e12b4' target=_blank style='color:#2F92EE;'>#朋友圈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60712, encryptionId=92bf60e12b4, topicName=朋友圈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca6426781117, createdName=axin018, createdTime=Mon Mar 06 06:18:00 CST 2017, time=2017-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134217, encodeId=54cb13421e0b, content=急救医学之路, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb571956164, createdName=187清风, createdTime=Sat Sep 24 10:07:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134218, encodeId=a8a113421870, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb571956164, createdName=187清风, createdTime=Sat Sep 24 10:07:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131589, encodeId=cce813158965, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:51:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131586, encodeId=8d93131586e6, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131587, encodeId=958d13158e8a, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131588, encodeId=4b2913158832, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131046, encodeId=f337131046f9, content=学习了啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e291719269, createdName=大旺旺, createdTime=Mon Sep 19 21:28:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130946, encodeId=141a130946a3, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 19 16:39:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130947, encodeId=0f3f13094e53, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 19 16:39:00 CST 2016, time=2016-09-19, status=1, ipAttribution=)]
    2016-09-24 187清风

    急救医学之路

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1670896, encodeId=ef2a16e0896a0, content=<a href='/topic/show?id=92bf60e12b4' target=_blank style='color:#2F92EE;'>#朋友圈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60712, encryptionId=92bf60e12b4, topicName=朋友圈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca6426781117, createdName=axin018, createdTime=Mon Mar 06 06:18:00 CST 2017, time=2017-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134217, encodeId=54cb13421e0b, content=急救医学之路, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb571956164, createdName=187清风, createdTime=Sat Sep 24 10:07:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134218, encodeId=a8a113421870, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb571956164, createdName=187清风, createdTime=Sat Sep 24 10:07:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131589, encodeId=cce813158965, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:51:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131586, encodeId=8d93131586e6, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131587, encodeId=958d13158e8a, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131588, encodeId=4b2913158832, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131046, encodeId=f337131046f9, content=学习了啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e291719269, createdName=大旺旺, createdTime=Mon Sep 19 21:28:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130946, encodeId=141a130946a3, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 19 16:39:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130947, encodeId=0f3f13094e53, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 19 16:39:00 CST 2016, time=2016-09-19, status=1, ipAttribution=)]
    2016-09-24 187清风

    继续关注

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1670896, encodeId=ef2a16e0896a0, content=<a href='/topic/show?id=92bf60e12b4' target=_blank style='color:#2F92EE;'>#朋友圈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60712, encryptionId=92bf60e12b4, topicName=朋友圈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca6426781117, createdName=axin018, createdTime=Mon Mar 06 06:18:00 CST 2017, time=2017-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134217, encodeId=54cb13421e0b, content=急救医学之路, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb571956164, createdName=187清风, createdTime=Sat Sep 24 10:07:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134218, encodeId=a8a113421870, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb571956164, createdName=187清风, createdTime=Sat Sep 24 10:07:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131589, encodeId=cce813158965, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:51:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131586, encodeId=8d93131586e6, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131587, encodeId=958d13158e8a, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131588, encodeId=4b2913158832, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131046, encodeId=f337131046f9, content=学习了啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e291719269, createdName=大旺旺, createdTime=Mon Sep 19 21:28:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130946, encodeId=141a130946a3, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 19 16:39:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130947, encodeId=0f3f13094e53, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 19 16:39:00 CST 2016, time=2016-09-19, status=1, ipAttribution=)]
    2016-09-20 el891227

    学习一下学习一下

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1670896, encodeId=ef2a16e0896a0, content=<a href='/topic/show?id=92bf60e12b4' target=_blank style='color:#2F92EE;'>#朋友圈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60712, encryptionId=92bf60e12b4, topicName=朋友圈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca6426781117, createdName=axin018, createdTime=Mon Mar 06 06:18:00 CST 2017, time=2017-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134217, encodeId=54cb13421e0b, content=急救医学之路, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb571956164, createdName=187清风, createdTime=Sat Sep 24 10:07:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134218, encodeId=a8a113421870, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb571956164, createdName=187清风, createdTime=Sat Sep 24 10:07:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131589, encodeId=cce813158965, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:51:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131586, encodeId=8d93131586e6, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131587, encodeId=958d13158e8a, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131588, encodeId=4b2913158832, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131046, encodeId=f337131046f9, content=学习了啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e291719269, createdName=大旺旺, createdTime=Mon Sep 19 21:28:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130946, encodeId=141a130946a3, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 19 16:39:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130947, encodeId=0f3f13094e53, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 19 16:39:00 CST 2016, time=2016-09-19, status=1, ipAttribution=)]
    2016-09-20 el891227

    学习一下学习一下

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1670896, encodeId=ef2a16e0896a0, content=<a href='/topic/show?id=92bf60e12b4' target=_blank style='color:#2F92EE;'>#朋友圈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60712, encryptionId=92bf60e12b4, topicName=朋友圈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca6426781117, createdName=axin018, createdTime=Mon Mar 06 06:18:00 CST 2017, time=2017-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134217, encodeId=54cb13421e0b, content=急救医学之路, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb571956164, createdName=187清风, createdTime=Sat Sep 24 10:07:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134218, encodeId=a8a113421870, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb571956164, createdName=187清风, createdTime=Sat Sep 24 10:07:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131589, encodeId=cce813158965, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:51:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131586, encodeId=8d93131586e6, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131587, encodeId=958d13158e8a, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131588, encodeId=4b2913158832, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131046, encodeId=f337131046f9, content=学习了啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e291719269, createdName=大旺旺, createdTime=Mon Sep 19 21:28:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130946, encodeId=141a130946a3, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 19 16:39:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130947, encodeId=0f3f13094e53, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 19 16:39:00 CST 2016, time=2016-09-19, status=1, ipAttribution=)]
    2016-09-20 el891227

    学习一下学习一下

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1670896, encodeId=ef2a16e0896a0, content=<a href='/topic/show?id=92bf60e12b4' target=_blank style='color:#2F92EE;'>#朋友圈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60712, encryptionId=92bf60e12b4, topicName=朋友圈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca6426781117, createdName=axin018, createdTime=Mon Mar 06 06:18:00 CST 2017, time=2017-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134217, encodeId=54cb13421e0b, content=急救医学之路, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb571956164, createdName=187清风, createdTime=Sat Sep 24 10:07:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134218, encodeId=a8a113421870, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb571956164, createdName=187清风, createdTime=Sat Sep 24 10:07:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131589, encodeId=cce813158965, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:51:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131586, encodeId=8d93131586e6, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131587, encodeId=958d13158e8a, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131588, encodeId=4b2913158832, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131046, encodeId=f337131046f9, content=学习了啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e291719269, createdName=大旺旺, createdTime=Mon Sep 19 21:28:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130946, encodeId=141a130946a3, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 19 16:39:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130947, encodeId=0f3f13094e53, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 19 16:39:00 CST 2016, time=2016-09-19, status=1, ipAttribution=)]
    2016-09-20 el891227

    学习一下学习一下

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1670896, encodeId=ef2a16e0896a0, content=<a href='/topic/show?id=92bf60e12b4' target=_blank style='color:#2F92EE;'>#朋友圈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60712, encryptionId=92bf60e12b4, topicName=朋友圈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca6426781117, createdName=axin018, createdTime=Mon Mar 06 06:18:00 CST 2017, time=2017-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134217, encodeId=54cb13421e0b, content=急救医学之路, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb571956164, createdName=187清风, createdTime=Sat Sep 24 10:07:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134218, encodeId=a8a113421870, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb571956164, createdName=187清风, createdTime=Sat Sep 24 10:07:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131589, encodeId=cce813158965, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:51:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131586, encodeId=8d93131586e6, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131587, encodeId=958d13158e8a, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131588, encodeId=4b2913158832, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131046, encodeId=f337131046f9, content=学习了啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e291719269, createdName=大旺旺, createdTime=Mon Sep 19 21:28:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130946, encodeId=141a130946a3, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 19 16:39:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130947, encodeId=0f3f13094e53, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 19 16:39:00 CST 2016, time=2016-09-19, status=1, ipAttribution=)]
    2016-09-19 大旺旺

    学习了啊

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1670896, encodeId=ef2a16e0896a0, content=<a href='/topic/show?id=92bf60e12b4' target=_blank style='color:#2F92EE;'>#朋友圈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60712, encryptionId=92bf60e12b4, topicName=朋友圈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca6426781117, createdName=axin018, createdTime=Mon Mar 06 06:18:00 CST 2017, time=2017-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134217, encodeId=54cb13421e0b, content=急救医学之路, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb571956164, createdName=187清风, createdTime=Sat Sep 24 10:07:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134218, encodeId=a8a113421870, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb571956164, createdName=187清风, createdTime=Sat Sep 24 10:07:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131589, encodeId=cce813158965, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:51:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131586, encodeId=8d93131586e6, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131587, encodeId=958d13158e8a, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131588, encodeId=4b2913158832, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131046, encodeId=f337131046f9, content=学习了啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e291719269, createdName=大旺旺, createdTime=Mon Sep 19 21:28:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130946, encodeId=141a130946a3, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 19 16:39:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130947, encodeId=0f3f13094e53, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 19 16:39:00 CST 2016, time=2016-09-19, status=1, ipAttribution=)]
    2016-09-19 知难而进

    谢谢分享!

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1670896, encodeId=ef2a16e0896a0, content=<a href='/topic/show?id=92bf60e12b4' target=_blank style='color:#2F92EE;'>#朋友圈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60712, encryptionId=92bf60e12b4, topicName=朋友圈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca6426781117, createdName=axin018, createdTime=Mon Mar 06 06:18:00 CST 2017, time=2017-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134217, encodeId=54cb13421e0b, content=急救医学之路, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb571956164, createdName=187清风, createdTime=Sat Sep 24 10:07:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=134218, encodeId=a8a113421870, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb571956164, createdName=187清风, createdTime=Sat Sep 24 10:07:00 CST 2016, time=2016-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131589, encodeId=cce813158965, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:51:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131586, encodeId=8d93131586e6, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131587, encodeId=958d13158e8a, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131588, encodeId=4b2913158832, content=学习一下学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ce350198, createdName=el891227, createdTime=Tue Sep 20 19:50:00 CST 2016, time=2016-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=131046, encodeId=f337131046f9, content=学习了啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e291719269, createdName=大旺旺, createdTime=Mon Sep 19 21:28:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130946, encodeId=141a130946a3, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 19 16:39:00 CST 2016, time=2016-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=130947, encodeId=0f3f13094e53, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Sep 19 16:39:00 CST 2016, time=2016-09-19, status=1, ipAttribution=)]
    2016-09-19 知难而进

    继续关注!

    0

相关资讯

羊水栓塞产妇获得***献血

至昨晚8时许,经过医护人员抢救和众位市民的爱心接力,产妇的病情趋于稳定,转移到重症监护室。 产妇羊水栓塞,生命垂危,情况紧急!求AB血型的市民紧急献血救助!  从昨天下午五点多到晚上,一条朋友圈消息引爆了整个泉城的爱心,得到消息的爱心人士纷纷前往济南市血液供保中心,伸出手臂,用自己的血液为这名产妇续命。至昨晚8时许,经过医护人员抢救和众位市民的爱心接力,产妇的病情趋于稳定,转移到重症监护

让他活着,便以为是爱他?

导  语:这些人在医院里度过最后的时光,他们全身插满管子,与各种监视仪器连在一起,照顾他们的则是一些陌生人。 生命时间大于生命质量的现象,是医疗化社会所产生的。死亡这一过程试图矫正它,但却在实践过程中被慢慢异化了。大多数绝症患者宁愿死在家中,在自己的床上,被家人和朋友的爱环绕着。然而,这些人绝大多数却还是在医院里度过最后的时光。他们全身插满管子,与各种监视仪器连在一起,照顾

一例羊水栓塞的抢救体会

导  语: 剖宫产手术过程中产妇突发胸闷,血压、血氧饱和度急剧下降,确诊为羊水栓塞。经护理人员与医生严密配合产妇转危为安,具体护理经验总结如下: 配合抢救 护理人员应及时识别羊水栓塞的临床表现以保证抢救能争分夺秒,按医嘱尽快给药并作详细记录,观察与判断疗效。 (1)解除肺动脉高压,纠正呼吸困难,最大限度地促进呼吸,增加氧气的进入,以维持生理功能。

临床危象诊断要点及抢救措施汇总,超实用!

临床危象,即疾病的危急征象,见于临床各科。危象的识别与救治是危重病急救医学的重要组成部分。 1、内分泌代谢系统  垂体危象:  本危象是垂体功能减退症未经系统、正规激素补充治疗出现的多种代谢紊乱和器官功能失调,是危及生命的危急重症之一。 诊断要点: 垂体功能减退症患者,遇感染、外伤、手术等应激状态,出现严重的代谢紊乱(低血钠、低血糖)

浙江三门:患者家属殴打医生已被警方抓获

一则《拒给尸体打强心针 浙江医生被群殴》的网文近日引发网民关注。记者11日从浙江三门县公安局获悉,患者系突发急病在医院抢救无效死亡,家属林某等人在不知已经抢救过的情况下,要求医院再行抢救未果,进而动手殴打医生。目前两名嫌疑人已被警方抓获。据介绍,3月9日8时20分许,一患者突发急病,在三门医院进行了紧急抢救,抢救无效后死亡。林某等患者家属情绪激动,在不知已经抢救过的情况下,要求院方再注射“强心针”

心痛!女医生抢救病人后流产……

导读:请医院给女医护人员更多关爱。东莞一女医生,在抢救病人后流产了。新浪微博知名博主“一个有点理想的记者”11日发微博称:9号晚间,在广东东莞的公立三甲医院,东莞厚街医院里,怀有13周身孕的35岁主治医生缪丽琳,彻夜值班抢救一名凶险性前置胎盘,子宫破裂,难治性产后大出血的妈妈,最终将患者抢救回来,而缪医生却在彻夜抢救加班30多个小时劳累不堪后,于昨日继续加班上午写病历时流产。今天,这条信息依然在其